arrow
Qingyi Wei 封面图

Qingyi Wei

the research institute for cancer control and prevention邮箱:weiqingyi@ipm-gba.org.cn
H指数:83
被引数:3.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of anti-PD-1 combined with IFN-α1b with or without anlotinib as the first-line therapy in patients with unresectable advanced melanoma: a real-world cohort study

PD-1抑制剂联合IFN-α1b,联合或不联合安罗替尼作为不可切除性晚期黑色素瘤患者的一线治疗:一项真实世界队列研究

2026-08-260
OA
Clinical efficacy of CDK4/6 inhibitor plus endocrine therapy in HR-positive/HER2-0 and HER2-low-positive metastatic breast cancer: a secondary analysis of PALOMA-2 and PALOMA-3 trials

CDK4/6抑制剂联合内分泌治疗HR阳性/HER2-0和HER2-low-positive转移性乳腺癌的临床疗效: PALOMA-2和PALOMA-3试验的二次分析

2024-07-013
OAAI
CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility

CYP2A6活性与吸烟相关肺癌易感性的相互作用

2023-12-201
PRE
Development, validation, and evaluation of a risk assessment tool for personalized screening of gastric cancer in Chinese populations

中国人群胃癌个性化筛查风险评估工具的开发、验证和评价

2023-04-278
OAAI